rdThursday, 23 September 2021

07.00 pm - 09.00 pm (IST)

EVOLVING PARADIGMSWITH BEVACIZUMAB IN

Supported by:

Organized by:

GYNECOLOGICAL MALIGNANCIES

http://miceideas.com/registration/gynec-malignancies/President, Medicine & Science,Cancer Treatment Centers of America

Director and Head of DepartmentMedical OncologyBhagwan Mahaveer Cancer Hospitaland Research Center, Jaipur

President, Medicine & Science, Cancer Treatment Centers of America

Prof. (Dr.) Maurie Markman, MD, is the President of Medicine & Science at Cancer Treatment Centers of America, a na�onal, comprehensive cancer care network. He is a renowned oncologist specializing in gynecologic malignancies, clinical research, and precision medicine with over 35+ years of experience at some of the country’s most recognized facili�es for cancer treatment. Most recently, Prof. (Dr.) Markman was the Vice President for Clinical Research and Chairman of the Department of Gynecologic Medical Oncology at the University of Texas M.D. Anderson Cancer Center. Prior to that, he served as Chairman in the Department of Hematology/Oncology and Director of The Cleveland Clinic Taussig Cancer Center.

Prof. (Dr.) Markman is widely known by his colleagues as an esteemed researcher with over 1,600 clinical research publica�ons and by his pa�ents as a “people’s doctor” dedicated to giving pa�ents every op�on to beat their disease. For his unwavering commitment to the field of oncology, he was inducted into the OncLive Giants of Cancer Care Class of 2018 and was honored by the American Society of Clinical Oncology (ASCO) with the Statesman Award for extraordinary service.

Today, Prof. (Dr.) Markman leads a talented team of board-cer�fied oncologists and physicians at CTCA in prac�cing high quality, evidence-based medicine.

EVOLVING PARADIGMSWITH BEVACIZUMAB IN

GYNECOLOGICAL MALIGNANCIES

Virtual Conference Managed by:

Leader in Virtual Conferences

M: +91 93740 73512 | E: rajesh@miceideas.in

07.00 pm - 07.05 pm Welcome Note and Speaker Introduc�ons Program Director: Dr. Ajay Bapna, Jaipur 07.05 pm - 07.25 pm CRS with HIPEC for Advanced Ovarian Cancer; ISPSM - HIPEC Registry of IndiaSpeaker: Dr. Somashekar SP, Bengaluru 07.25 pm - 07.55 pm Evolving paradigms with Bevacizumab in Gynecological Malignancies Speaker: Prof. (Dr.) Maurie Markman, USA 07.55 pm - 08.10 pm Q&A and Quiz for A�endees 08.10 pm - 08.50 pm Moderated Debate: Targeted Therapy vs Novel Agents in Gynecological Malignancies Moderator: Dr. Indranil Ghosh, Kolkata

Panelists:

08.50 pm - 08.55 pm Closing Remarks

SCIENTIFIC PROGRAM

Novel Agents:Dr. Amit Bhargava. DelhiDr. Venugopal A, Hyderabad Dr. Sanath.K, HyderabadDr. Harshvardhan Atreya, LucknowDr. P N Mohapatra, Kolkata

Targeted Therapy: Dr. Kaushal Kalra, DelhiDr. Adwaita Gore, MumbaiDr. S Suresh, ChennaiDr. Ravi Diwakar, BengaluruDr. Ajmal Sheriff, Calicut

Speaker

Moderator

Panelists

Panelists

Panelists